The Community Support Medication Program (CSMP) is a payment source of last resort and is distributed on a first-come, first-served basis. The program supports persons who reside in Kansas and are in need of an atypical antipsychotic and/or antidepressant medication, such as Depakote, Lamicta, or Prolixin, for treatment of their mental illness. Without the support of these medications, program recipients would be at risk for hospitalization. Consideration of generic forms of medication and alternative funding sources are expected.
An individual must meet the three following criteria:
- Clinical need
- At-risk need
- Financial need
For more information on applying for the CSMP, please contact your local community mental health center or prescribing physician.